Loading...
Market
How much funding or grant will Eli Lilly's genetic medicine center secure by the end of 2024?
3
Resolution / Starting Odds
Less than $100 million • 25%
$100 million to $200 million • 25%
$200 million to $300 million • 25%
More than $300 million • 25%
Official announcements from Eli Lilly or reputable news sources
Story
Eli Lilly Opens $700 Million Genetic Medicine Center in Fort Point, Boston
Aug 13, 2024, 01:14 PM
Eli Lilly has inaugurated a new $700 million center for genetic medicine in Fort Point, Boston Seaport. The facility will focus on RNA- and DNA-based drugs and novel treatments for conditions such as diabetes, obesity, heart disease, and chronic pain. Over 200 employees have relocated from Cambridge to the new research and development center, which will also house a biotech incubator for startups. The company plans to hire an additional 300 employees, bringing the total workforce in Boston to 500. Eli Lilly's investment in genetic medicine includes the acquisition of Prevail Therapeutics for approximately $1.5 billion in 2020 and Akouos for $487 million in 2022.
View original story
Similar markets
Less than $4.5 billion • 25%
$4.5 billion to $5 billion • 25%
$5 billion to $5.5 billion • 25%
More than $5.5 billion • 25%
Less than $25 billion • 25%
$25 billion to $30 billion • 25%
$30 billion to $35 billion • 25%
More than $35 billion • 25%
No additional funding • 25%
Up to $10 million • 25%
$10 million to $50 million • 25%
Over $50 million • 25%
Full agreement executed • 25%
Partial execution • 25%
Agreement terminated • 25%
No significant progress • 25%
Yes • 50%
No • 50%
Major success • 25%
Moderate success • 25%
Limited success • 25%
Failure • 25%
Yes • 50%
No • 50%
0 to 2 • 25%
3 to 5 • 25%
6 to 8 • 25%
More than 8 • 25%
Up to $150 million • 25%
Up to $300 million • 25%
Up to $500 million • 25%
Up to $720 million • 25%
$45.4 billion to $46.6 billion • 25%
Less than $45.4 billion • 25%
More than $46.6 billion • 25%
Between $46.0 billion and $46.6 billion • 25%